Back to top

dna-sequencing: Archive

Zacks Equity Research

Inovio Pharma (INO) Stock Surges 19% This Month: Here's Why

Inovio Pharma (INO) rises 19% this month after the FDA issues positive feedback on data from a phase I/II study on a rare respiratory disease candidate, INO-3107, which can be used to file a BLA.

DVAXPositive Net Change ACETPositive Net Change INOPositive Net Change ANIXPositive Net Change